The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
Open accessAbstract
OBJECTIVE: To assess the potential role of FoxP3-expressing regulatory T cells (Tregs) in reversing obesity-linked insulin resistance and diabetic nephropathy in rodent models and humans. RESEARCH DESIGN AND METHODS: To characterize the role of Tregs in insulin resistance, human visceral adipose tissue was first evaluated for Treg infiltration and second, the db/db mouse model was evaluated. RESULTS: Obese patients with insulin resistance displayed significantly decreased natural Tregs but an increase in adaptive Tregs in their visceral adipose tissue as compared with lean control subjects. To further evaluate the pathogenic role of Tregs in insulin resistance, the db/db mouse model was used. Treg depletion using an anti-CD25 monoclonal antibody enhanced insulin resistance as shown by increased fasting blood glucose levels as well as an impaired insulin sensitivity. Moreover, Treg-depleted db/db mice developed increased signs of diabetic nephropathy, such as albuminuria and glomerular hyperfiltration. This was paralleled by a proinflammatory milieu in both murine visceral adipose tissue and the kidney. Conversely, adoptive transfer of CD4+FoxP3+ Tregs significantly improved insulin sensitivity and diabetic nephropathy. Accordingly, there was increased mRNA expression of FoxP3 as well as less abundant proinflammatory CD8+CD69+ T cells in visceral adipose tissue and kidneys of Treg-treated animals. CONCLUSIONS: Data suggest a potential therapeutic value of Tregs to improve insulin resistance and end organ damage in type 2 diabetes by limiting the proinflammatory milieu.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“Since T-cell activation markers such as CD69 and CD25 are expressed only on a small fraction of the two memory subsets (32), it can be proposed that Treg transfer decreased the mVAT infiltration of effector CD8 T cells, which originated from naïve CD8 T cells.”
BackgroundA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382
Normalization of obesity-associated insulin resistance through immunotherapy
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2001 · Cited by 1,370
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Identification of IL-17-producing FOXP3+regulatory T cells in humans
Voo, K. S., Wang, Y.-H., Santori, F. R., Boggiano, C., Wang, Y.-H., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900408106 · Cited by 689
Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmüller, U., Baron, U., Olek, S., Bluestone, J. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003099 · Cited by 428
Cao, D., Vollenhoven, R. V., Klareskog, L., Trollmo, C., & Malmström, V. (2004) · Arthritis Res Ther · doi:10.1186/ar1192 · Cited by 359
Ilan, Y., Maron, R., Tukpah, A.-M., Maioli, T. U., Murugaiyan, G., Yang, K., Wu, H. Y., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908771107 · Cited by 327
Deiuliis, J., Shah, Z., Shah, N., Needleman, B., Mikami, D., Narula, V., Perry, K., Hazey, J., Kampfrath, T., Kollengode, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016376 · Cited by 314
Seddon, B., & Mason, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.279 · Cited by 255
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo
Siegmund, K., Feuerer, M., Siewert, C., Ghani, S., Haubold, U., Dankof, A., Krenn, V., Schön, M. P., Scheffold, A., Lowe, J. B., et al. (2005) · Blood · doi:10.1182/blood-2005-05-1864 · Cited by 246
Wolf, D., Hochegger, K., Wolf, A. M., Rumpold, H. F., Gastl, G., Tilg, H., Mayer, G., Gunsilius, E., & Rosenkranz, A. R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100837 · Cited by 184
Self-citationLumeng, C. N.-K., Maillard, I. P., & Saltiel, A. R. (2009) · Nature Medicine · doi:10.1038/nm0809-846 · Cited by 163
Therapeutic vaccination using CD4 + CD25 + antigen-specific regulatory T cells
Bluestone, J. A., & Tang, Q. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405234101 · Cited by 156
Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney
Kinsey, G. R., Huang, L., Vergis, A. L., Li, L., & Okusa, M. D. (2010) · Kidney International · doi:10.1038/ki.2010.12 · Cited by 151
Couper, K. N., Blount, D. G., de Souza, J. B., Suffia, I., Belkaid, Y., & Riley, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4136 · Cited by 150
A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation
Foussat, A., Cottrez, F., Brun, V., Fournier, N., Breittmayer, J., & Groux, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5018 · Cited by 150
Zeyda, M., Huber, J., Prager, G., & Stulnig, T. M. (2010) · Obesity · doi:10.1038/oby.2010.123 · Cited by 143
Haeryfar, S. M. M., DiPaolo, R. J., Tscharke, D. C., Bennink, J. R., & Yewdell, J. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3344 · Cited by 129
Rosenkranz, A. R., Mendrick, D. L., Cotran, R. S., & Mayadas, T. N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5183 · Cited by 120
Self-citationSalama, A. D., Chaudhry, A., Holthaus, K. A., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00259.x · Cited by 115
The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice
Ninichuk, V., Khandoga, A. G., Segerer, S., Loetscher, P., Schlapbach, A., Révész, L., Feifel, R., Khandoga, A., Krombach, F., Nelson, P. J., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060937 · Cited by 92
Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans
Oberkofler, H., Pfeifenberger, A., Soyal, S. M., Felder, T. K., Hahne, P., Miller, K., Krempler, F., & Patsch, W. (2010) · Diabetologia · doi:10.1007/s00125-010-1772-2 · Cited by 59
Self-citationAllogeneic induced human FOXP3+IFN‐γ+ T cells exhibit selective suppressive capacity
Stroopinsky, D., Avivi, I. M., Rowe, J. M., Avigan, D., & Katz, T. (2009) · European Journal of Immunology · doi:10.1002/eji.200839097 · Cited by 28
Research works printed but not linked: 1
- Almeida, 2010, CD4+ CD25+ Treg regulate the contribution of CD8+ T-cell subsets in repopulation of the lymphopenic environment, Eur J Immunol, 40, 3478, 10.1002/eji.201040600 · doi:10.1002/eji.201040600
Cited by
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Macrophages, Immunity, and Metabolic Disease
McNelis, J. C., & Olefsky, J. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.010 · Cited by 720
Diabetic nephropathy – complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583
Panduro, M., Benoist, C., & Mathis, D. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095948 · Cited by 536
Pettersson, U. S., Waldén, T. B., Carlsson, P.-O., Jansson, L., & Phillipson, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046057 · Cited by 520
Metadata
- Authors
- Eller, K., Kirsch, A., Wolf, A. M., Sopper, S., Tagwerker, A., Stanzl, U., Wolf, D., Patsch, W., Rosenkranz, A. R., & Eller, P.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-10-17
- Volume
- 60
- Issue
- 11
- Pages
- 2954-2962
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2131517624
- Cited by
- 318
- References
- 33
- FWCI
- 12.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.